Hippius H, Neundörfer G (2003) The discovery of Alzheimer’s disease. Dialogues Clin Neurosci 5:101. https://doi.org/10.31887/DCNS.2003.5.1/HHIPPIUS

Article  PubMed  PubMed Central  Google Scholar 

Srivastava S, Ahmad R, Khare SK (2021) Alzheimer’s disease and its treatment by different approaches: A review. Eur J Med Chem 216:. https://doi.org/10.1016/J.EJMECH.2021.113320

Torromino G, Maggi A, de Leonibus E (2021) Estrogen-dependent hippocampal wiring as a risk factor for age-related dementia in women. Prog Neurobiol 197:101895. https://doi.org/10.1016/J.PNEUROBIO.2020.101895

Article  CAS  PubMed  Google Scholar 

Cc T, Jt Y, Hf W et al (2014) Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis 41:615–631. https://doi.org/10.3233/JAD-132690

Article  CAS  Google Scholar 

Hung ASM, Liang Y, Chow TCH et al (2016) Mutated tau, amyloid and neuroinflammation in Alzheimer disease—A brief review. Prog Histochem Cytochem 51:1–8. https://doi.org/10.1016/J.PROGHI.2016.01.001

Article  CAS  PubMed  Google Scholar 

Annaert W, de Strooper B (2002) A cell biological perspective on Alzheimer’s disease. Annu Rev Cell Dev Biol 18:25–51. https://doi.org/10.1146/ANNUREV.CELLBIO.18.020402.142302

Article  CAS  PubMed  Google Scholar 

Ashrafian H, Zadeh EH, Khan RH (2021) Review on Alzheimer’s disease: Inhibition of amyloid beta and tau tangle formation. Int J Biol Macromol 167:382–394

Article  CAS  PubMed  Google Scholar 

Hardy J (2003) The relationship between amyloid and tau. J Mol Neurosci 2003 20:2 20:203–206. https://doi.org/10.1385/JMN:20:2:203

Stambolic V, Ruel L, Woodgett JR (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6:1664–1669. https://doi.org/10.1016/S0960-9822(02)70790-2

Article  CAS  PubMed  Google Scholar 

Embi N, Rylatt DB, Cohen P (1980) Glycogen synthase kinase-3 from rabbit skeletal muscle. Eur J Biochem 107:519–527. https://doi.org/10.1111/J.1432-1033.1980.TB06059.X

Article  CAS  PubMed  Google Scholar 

Woodgett JR, Waterfield M (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J 9:2431. https://doi.org/10.1002/J.1460-2075.1990.TB07419.X

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao C, Hlscher C, Liu Y, Li L (2012) GSK3: A key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease. Rev Neurosci 23:1–11. https://doi.org/10.1515/RNS.2011.061/MACHINEREADABLECITATION/RIS

Article  CAS  Google Scholar 

Juhaszova M, Zorov DB, Yaniv Y et al (2009) Role of glycogen synthase kinase-3β in cardioprotection. Circ Res 104:1240. https://doi.org/10.1161/CIRCRESAHA.109.197996

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kawazoe H, Bilim VN, Ugolkov AV et al (2012) GSK-3 inhibition in vitro and in vivo enhances antitumor effect of sorafenib in renal cell carcinoma (RCC). Biochem Biophys Res Commun 423:490–495. https://doi.org/10.1016/J.BBRC.2012.05.147

Article  CAS  PubMed  Google Scholar 

Mccubrey JA, Steelman LS, Bertrand FE et al (2014) GSK-3 as potential target for therapeutic irvention in cancer. Oncotarget 5:2881–2911. https://doi.org/10.18632/ONCOTARGET.2037

Article  PubMed  PubMed Central  Google Scholar 

Hermida MA, Dinesh Kumar J, Leslie NR (2017) GSK3 and its interactions with the PI3K/AKT/mTOR signalling network. Adv Biol Regul 65:5–15. https://doi.org/10.1016/J.JBIOR.2017.06.003

Article  CAS  PubMed  Google Scholar 

Huang J, Guo X, Li W, Zhang H (2017) Activation of Wnt/β-catenin signalling via GSK3 inhibitors direct differentiation of human adipose stem cells into functional hepatocytes. Sci Rep 2017 7:1 7:1–12. https://doi.org/10.1038/srep40716

Noori T, Dehpour AR, Sureda A et al (2020) The role of glycogen synthase kinase 3 beta in multiple sclerosis. Biomed Pharmacother 132:. https://doi.org/10.1016/J.BIOPHA.2020.110874

Maurer U, Preiss F, Brauns-Schubert P et al (2014) GSK-3 – at the crossroads of cell death and survival. J Cell Sci 127:1369–1378. https://doi.org/10.1242/JCS.138057

Article  CAS  PubMed  Google Scholar 

Nimmo HG, Proud CG, Cohen P (1976) The phosphorylation of rabbit skeletal muscle glycogen synthase by glycogen synthase kinase-2 and adenosine-3′: 5′-monophosphate-dependent protein kinase. Eur J Biochem 68:31–44. https://doi.org/10.1111/j.1432-1033.1976.tb10762.x

Article  CAS  Google Scholar 

Kim M, Datta A, Brakeman P et al (2007) Polarity proteins PAR6 and aPKC regulate cell death through GSK-3β in 3D epithelial morphogenesis. J Cell Sci 120:2309–2317. https://doi.org/10.1242/JCS.007443

Article  CAS  PubMed  Google Scholar 

Kim WY, Snider WD (2011) Functions of GSK-3 signaling in development of the nervous system. Front Mol Neurosci 4:. https://doi.org/10.3389/FNMOL.2011.00044/FULL

Hongo H, Kihara T, Kume T et al (2012) Glycogen synthase kinase-3β activation mediates rotenone-induced cytotoxicity with the involvement of microtubule destabilization. Biochem Biophys Res Commun 426:94–99. https://doi.org/10.1016/J.BBRC.2012.08.042

Article  CAS  PubMed  Google Scholar 

Manceur AP, Tseng M, Holowacz T et al (2011) Inhibition of glycogen synthase kinase-3 enhances the differentiation and reduces the proliferation of adult human olfactory epithelium neural precursors. Exp Cell Res 317:2086–2098. https://doi.org/10.1016/J.YEXCR.2011.06.004

Article  CAS  PubMed  Google Scholar 

Nayak G, Cooper GM (2012) p53 is a major component of the transcriptional and apoptotic program regulated by PI 3-kinase/Akt/GSK3 signaling. Cell Death Dis 3:. https://doi.org/10.1038/CDDIS.2012.138

Sutherland C, Leighton IA, Cohen P (1993) Inactivation of glycogen synthase kinase-3β by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296:15–19. https://doi.org/10.1042/BJ2960015

Article  CAS  PubMed  PubMed Central  Google Scholar 

Perez-Costas E, Gandy JC, Melendez-Ferro M et al (2010) Light and Electron Microscopy Study of Glycogen Synthase Kinase-3β in the Mouse Brain. PLoS One 5:. https://doi.org/10.1371/JOURNAL.PONE.0008911

Fang X, Yu SX, Lu Y et al (2000) Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci U S A 97:11960–11965. https://doi.org/10.1073/PNAS.220413597

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou X, Wang H, Burg MB, Ferraris JD (2013) Inhibitory phosphorylation of GSK-3β by AKT, PKA, and PI3K contributes to high NaCl-induced activation of the transcription factor NFAT5 (TonEBP/OREBP). Am J Physiol Renal Physiol 304:F908. https://doi.org/10.1152/AJPRENAL.00591.2012

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cole AR (2013) Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia. FEBS J 280:5213–5227. https://doi.org/10.1111/FEBS.12407

Article  CAS  PubMed  Google Scholar 

Jope R, Roh M-S (2012) Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets 7:1421–1434. https://doi.org/10.2174/1389450110607011421

Article  Google Scholar 

Benedetti F, Serretti A, Colombo C et al (2004) A glycogen synthase kinase 3-β promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. Neurosci Lett 368:123–126. https://doi.org/10.1016/J.NEULET.2004.06.050

Article  CAS  PubMed  Google Scholar 

Kermode AG, Thompson AJ, Tofts P et al (1990) Breakdown of the blood-brain barrier precedes symptoms and other mri signs of new lesions in multiple sclerosis. Pathogenetic Clin Implications Brain 113:1477–1489. https://doi.org/10.1093/BRAIN/113.5.1477

Article  Google Scholar 

McArthur JC (2004) HIV dementia: an evolving disease. J Neuroimmunol 157:3–10. https://doi.org/10.1016/J.JNEUROIM.2004.08.042

Article  CAS  PubMed  Google Scholar 

Mobashir M, Madhusudhan T, Isermann B et al (2014) Negative interactions and feedback regulations are required for transient cellular response. Sci Rep 2014 4:1 4:1–8. https://doi.org/10.1038/srep03718

Mobashir M, Schraven B, Beyer T (2012) Simulated evolution of signal transduction networks. PLoS One 7:e50905. https://doi.org/10.1371/JOURNAL.PONE.0050905

Article  CAS  PubMed  PubMed Central  Google Scholar 

de La Monte SM, Tong M, Lester-Coll N et al (2006) Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer’s disease. J Alzheimers Dis 10:89–109. https://doi.org/10.3233/JAD-2006-10113

Article  PubMed  Google Scholar 

Woodgett JR, Cormier KW (2017) Recent advances in understanding the cellular roles of GSK-3. F1000Res 6:. https://doi.org/10.12688/F1000RESEARCH.10557.1

Azoulay-Alfaguter I, Yaffe Y, Licht-Murava A et al (2011) Distinct molecular regulation of glycogen synthase kinase-3α isozyme controlled by its n-terminal region: functional role in calcium/calpain signaling. J Biol Chem 286:13470–13480. https://doi.org/10.1074/JBC.M110.127969

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mukai F, Ishiguro K, Sano Y, Fujita SC (2002) Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3beta. J Neurochem 81:1073–1083. https://doi.org/10.1046/J.1471-4159.2002.00918.X

Article  CAS  PubMed